The latest Drug Administration Law amendments introduce welcome changes such as relaxed permit requirements and free prices. Pharmaceutical companies should keep abreast of the drug pricing reform, and track review and approval changes in the pipeline

The latest Drug Administration Law amendments introduce welcome changes such as relaxed permit requirements and free prices. Pharmaceutical companies should keep abreast of the drug pricing reform, and track review and approval changes in the pipeline

SIPO strengthens IP protection in exhibitions.

The PBOC has launched certificates for financial deposits, SIPO has required the patent administrative department to handle infringing items at exhibitions and PPP has been further encouraged in public service sectors

CBRC relaxes M&A loan requirements.

Government pricing removed from pharmaceuticals.

Issued: May 6 2015Main contents: The Draft reduces specific pricing items to 25, representing a reduction of approximately 80% as compared to the 2001…

NDRC puts forward reform of the share offering registration system.

China lays down its 10-year plan for becoming a manufacturing superpower.